Heterologous Prime-boost Immunization with an Aerosolised Adenovirus Type-5 Vector-based COVID-19 Vaccine (Ad5-nCoV) After Priming with an Inactivated SARS-CoV-2 Vaccine
Clinical trial NCT05043259 · COMPLETED
Trial details
- NCT number
- NCT05043259
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-14
- Primary completion
- 2021-11-01
- Enrollment
- 423
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.